Who is sponsoring NCT00197236?

NCT00197236 is sponsored by GlaxoSmithKline.

What condition does NCT00197236 study?

NCT00197236 studies Hepatitis A.

What drugs are being tested in NCT00197236?

Interventions: Havrix™, Infanrix™, ActHIB™.

What is the status of NCT00197236?

NCT00197236 is currently COMPLETED.

Last reviewed 2018-08-20 · How we verify

Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months

NCT00197236 PHASE3 COMPLETED Results posted

This is a study to evaluate the immune response and safety of GSK Biologicals 2-dose inactivated hepatitis A vaccine when administered with a diphtheria, tetanus and pertussis combination (DTaP) vaccine and a Haemophilus influenza type B (Hib) vaccine in children 15 months of age. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

Details

Lead sponsor	GlaxoSmithKline
Phase	PHASE3
Status	COMPLETED
Enrolment	468
Start date	Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Dec 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Hepatitis A

Interventions

Havrix™
Infanrix™
ActHIB™

Countries

United States